Results from a phase I clinical trial with IGN311, a fully humanized IgG1 antibody against Lewis Y in patients with solid tumors expressing Lewis Y antigen
2004 ◽
Vol 22
(14_suppl)
◽
pp. 2624-2624
◽
Keyword(s):
Phase I
◽
2012 ◽
Vol 70
(6)
◽
pp. 843-853
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS146-TPS146
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. e15176-e15176
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. TPS3124-TPS3124
2005 ◽
Vol 58
(1)
◽
pp. 107-116
◽